IGFBP4 Protein
Quick Overview for IGFBP4 Protein (ABIN7849677)
Target
See all IGFBP4 ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Purpose
- Recombinant Human IGFBP4 Protein
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCl, 300 mM NaCl, pH 9.0 with 0.2 % SKL as the preservative.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Ship at 4°C. Upon receipt, aliquot and store at -20°C for long term. Avoid repeated freeze and thaw cycles.
-
-
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Alternative Name
- IGFBP4
-
Background
-
Synonyms: Insulin-like growth factor-binding protein 4, IGFBP4, IBP-4, IGF-binding protein 4, IGFBP-4, IBP4
Description: Recombinant human Insulin Like Growth Factor Binding 4 protein with molecular weight of 31.7 kDa.
Background: Insulin-like growth factor-binding protein 4 is a protein that in humans is encoded by the IGFBP4 gene.IGFBP4 maternal blood concentrations were lower during pregnancy than during non-pregnant cycles and synchronized control cycles. It can be speculated that the lower IGFBP4 in maternal blood may result in an increase of free IGF1 for local action. IGFBP4 downregulation in GCTs compared to MSCs. Overexpression of UCHL1 and IGFBP4 by stable transfection of GCTSC did not influence cell viability, proliferation, migration and chemosensitivity compared to parental cells. However, colony-formation was significantly decreased suggesting that rescue of UCHL1 and IFGBP4 suppresses clonogenicity of GCT stromal cells. Epigenetic silencing of UCHL1 and IGFBP4 in GCTs might thus be a crucial event during the malignant transformation of MSCs in the context of GCT development and represent promising targets for the development of new diagnostic and therapeutic strategies.
-
Pathways
- WNT Signaling, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
Target
-